The following is a summary of “Long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD,” ...
Please provide your email address to receive an email when new articles are posted on . Patients on tolvaptan had an eGFR decline of 1.40 mL/min/1.73 m² per year. Annual rate of eGFR decline in ...
The Hearty Soul on MSN9d
Scientists Have Successfully Grown ‘Mini Kidneys' and Implanted Them Into a Live SubjectScientists at Nanyang Technological University, Singapore (NTU Singapore), have made a crucial breakthrough by successfully ...
Expert Rev Cardiovasc Ther. 2008;6(5):601-608. The first Phase III clinical trial to study tolvaptan was the Study of Ascending Levels of Tolvaptan in Hyponatremia (SALT)-1/-2, which consisted of ...
Oral administration of the vasopressin V2-receptor antagonist tolvaptan is safe and effective for the treatment of chronic hyponatremia in the long term, according to the results of the SALTWATER ...
Tolvaptan is a vasopressin receptor antagonist. Vasopressin (a.k.a. ADH or antidiuretic hormone) helps to regulate water retention by absorbing water in the collecting ducts of the nephron.
Discover the commercial and brand names of the generic drug Tolvaptan. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback